KEY PRODUCTS
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
01 1Sichuan Qingmu Pharmaceutical
01 1LENVATINIB MESYLATE
01 1China
01 1Active
01 1Blank
Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41489
Submission : 2025-03-24
Status : Active
Type : II
20
Sichuan Qingmu Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Qingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.
One of their notable products is LENVATINIB MESYLATE, with a corresponding US DMF Number 41489.
Remarkably, this DMF maintains an Active status since its submission on March 24, 2025, highlighting commitment to regulatory compliance.
